Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449
Heart Valves01:16

Heart Valves

13.2K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
13.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

420
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
420
Venous Return01:04

Venous Return

13.3K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
13.3K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.7K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.7K
Veins01:17

Veins

9.4K
Veins are an integral part of our circulatory system, serving as the blood vessels that transport blood from all body regions to the heart. They are a network of hollow tubes that carry blood low in oxygen from the body's cells back to the heart for reoxygenation. Veins are crucial for maintaining the body's overall fluid balance and the continuous circulation of blood.
Structure of Veins:
The structure of veins is specifically designed to assist in the low-pressure transportation of...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjunctive optical and magnetic stimulation for venous and mixed etiology leg ulcers: protocol for the NAZARÉ multicenter randomized controlled trial.

Trials·2026
Same author

Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Multiomics analysis reveals dermokine as a regulator of keratinocyte differentiation and adhesion.

JCI insight·2026
Same author

Biophysical and Raman Spectroscopy assessment of drug-induced photosensitivity: Insights from a randomised controlled pilot study.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Small Diameter Vascular Grafts Made in Minutes.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Cardiovascular stent technologies for coronary and valvular heart disease: the potential of 3D printing for stent fabrication.

Nature reviews. Cardiology·2026

Related Experiment Video

Updated: Mar 14, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.3K

Bioengineered valves for the venous circulation.

Benedikt Weber1,2,3, Jürg Hafner3, Torsten Willenberg4

  • 1a Institute for Regenerative Medicine , University of Zurich , Zurich , Switzerland.

Expert Review of Medical Devices
|October 1, 2016
PubMed
Summary
This summary is machine-generated.

Bioengineered venous valves offer new hope for treating deep venous reflux, a common vascular issue. Future research aims to overcome challenges like preventing blood clots for successful clinical use.

Keywords:
Vascular bioengineeringchronic venous diseaserefluxthrombogenicityvenous valve replacementvenous valves

More Related Videos

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

21.1K
A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch
07:51

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

Published on: December 10, 2020

6.3K

Related Experiment Videos

Last Updated: Mar 14, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.3K
Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

21.1K
A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch
07:51

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

Published on: December 10, 2020

6.3K

Area of Science:

  • Vascular Surgery
  • Regenerative Medicine
  • Biomedical Engineering

Background:

  • Chronic venous valve insufficiency is a significant global health burden.
  • Superficial venous valve insufficiency has effective treatments, but deep venous reflux options are limited.
  • Bioengineered venous valves show promise for treating deep venous insufficiency.

Purpose of the Study:

  • To review current literature on venous valve replacement and bioengineering.
  • To discuss limitations and potential solutions for clinical translation of bioengineered valves.
  • To explore future therapeutic options for severe deep venous reflux.

Main Methods:

  • Literature review of preclinical in vivo studies and clinical trials.
  • Analysis of technical and medical limitations in current bioengineering approaches.
  • Discussion of emerging technologies for overcoming these limitations.

Main Results:

  • Venous valve bioengineering has advanced, with preclinical and early clinical data available.
  • Significant technical and medical hurdles remain for widespread clinical application.
  • Thromboembolic complication prevention is a critical challenge for translation.

Conclusions:

  • Bioengineered venous valves represent a promising future treatment for specific patient groups with venous valve disease.
  • Overcoming thromboembolic risks is essential for the successful clinical implementation of these technologies.
  • Further research and technological advancements are needed to realize the full potential of bioengineered venous valves.